Skip to main content
. 2010 Feb;176(2):687–698. doi: 10.2353/ajpath.2010.090222

Table 1.

Morphometric Data from Hearts

Sham (n = 10) DOX + LacZ (n = 10) DOX + sFas (n = 10)
Heart weight (mg) 95 ± 2.1 81 ± 4.3* 83 ± 3.1*
Body weight (g) 26 ± 0.4 23 ± 0.7* 22 ± 0.7*
Heart to body weight ratio (mg/g) 3.7 ± 0.06 3.6 ± 0.13 3.7 ± 0.17
Size of myocyte (μm) 14.0 ± 0.2 12.3 ± 0.1* 12.6 ± 0.3*
CD45+ cells (/HPF) 4.4 ± 0.28 7.6 ± 0.41* 4.8 ± 0.34*
% fibrosis 0.46 ± 0.02 1.04 ± 0.07* 0.73 ± 0.06*
8-OHdG+ cells (/HPF) 1.5 ± 0.1 16 ± 0.2* 4.5 ± 0.1*

DOX, doxorubicin. 

*

P < 0.05 versus the sham group. 

P < 0.05 versus the LacZ-treated group.